Deployment
Toumai at Rome, Italy
The Toumai Endoscopic Surgical Robot is MicroPort MedBot's flagship laparoscopic surgical robotics system, featuring remote telesurgery capabilities. It became the world's first surgical robot to receive regulatory approval for commercial remote surgery in April 2025, and has been deployed in nearly 40 countries across six continents. Toumai has achieved 100+ commercial orders and 80+ installations worldwide, with notable deployments including Cleveland Clinic Abu Dhabi, Gemelli Hospital Italy, and AZ Delta Belgium.
Toumai by MicroPort MedBot · Unverified
Machine-readable surfaces
- Markdown mirror: /deployments/toumai-gemelli-hospital-rome.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/robots/b27a2bd0-1011-4f62-8b3e-1a380510f38a
- Data documentation: /data
- Query this programmatically: Deploy MCP
Gemelli Hospital in Italy completed over 50 cases using Toumai
Key facts
- Cases
- 50+ procedures completed
Safety record
No incidents on record for Toumai at Rome, Italy.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
- Trust tier
- Unverifiedhow tiers work →
- Last updated
- 2026-07-15
- Model
- Toumai
- Company
- MicroPort MedBot
- Location
- Rome, Italy
- Status
- operational
- First seen
- 2024-01-01
- ID
b27a2bd0-1011-4f62-8b3e-1a380510f38a
Timeline
- Jan 2024First recordedToumai first documented operating at Rome, Italy.
- Jul 2026Current status: operationalLatest recorded state. New status transitions append here as the deployment-status recorder produces them.
On the deployment map
Toumai operates in Rome, Italy. Explore the full verified map:
Sources (1)
- Toumai Achieves Global Commercialization Milestone · https://microport.com/news/toumai-surgical-robot-achieves-global-commercialization-milestone-with-100-orders · 2025-10-09
Methodology: Unreviewed · 1 source (1 primary) · last reviewed 2026-07-15
Verification posture
Unreviewed
Low confidence
Review state
Stable
Last reviewed 2026-07-15
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Toumai at Rome, Italy.Common questions
- What is the Toumai deployment at Rome, Italy?
- Toumai, built by MicroPort MedBot, is recorded as a deployment at Rome, Italy on the DEPLOY registry. MicroPort MedBot operates the deployment directly.
- Who operates Toumai at Rome, Italy?
- MicroPort MedBot, the manufacturer of Toumai, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
- When did the Toumai deployment at Rome, Italy go live?
- The deployment is recorded as starting January 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
- Have there been incidents at the Toumai deployment at Rome, Italy?
- No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.
Deploy Watch
Track this deployment.
We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.